QP Strategy & Release Readiness

Build QP Requirements into the Programme Early

QULLA helps sponsors and manufacturing partners design practical QP strategies for clinical and commercial supply, especially where products, testing or manufacturing originate outside the EU.

What QULLA Delivers

  • Early definition of QP, importer and MIA responsibilities
  • Release-document and Product Specification File readiness
  • Risk-based assessment of ex-EU manufacturers and laboratories
  • Alignment across IMPD, quality agreements, testing and supply timelines

Senior-Led, Risk-Based Support

QULLA provides QP strategy, pre-assessment and release-readiness support. Legal batch certification or QP declaration is performed through the appropriately licensed MIA and its named QP.

Discuss Your Programme

Questions

Frequently Asked Questions

Why involve a QP before the first clinical batch?

Early QP input exposes documentation, audit, testing, importation and supply-chain gaps while they can still be resolved without delaying a trial.

Does QULLA itself provide legal batch certification?

QULLA supports the strategy and readiness work. Legal certification is performed by the QP named under the relevant manufacturing and import authorization.

Explore all QULLA services · Read the Purple Papers · About Richard van Ewijk

Who We Serve

Built for the Complexity of Modern Drug Development

We work with organizations where the stakes are high and quality excellence is non-negotiable — from advisory to hands-on execution.

Emerging & Clinical-Stage Biotech

Whether entering Phase I or scaling toward later-stage development, we help build quality infrastructure that matches ambition without overbuilding for the current stage.

  • Phase-appropriate QMS design and implementation
  • QP services and IMP quality oversight
  • CMC quality strategy for regulatory submissions
  • Quality DD support for fundraising and licensing

CDMOs & Contract Manufacturers

We help CDMOs sharpen their quality positioning, strengthen governance structures, and demonstrate the operational robustness that clients and regulators demand.

  • QMS optimization and scalability review
  • Audit program design and execution
  • GxP readiness and inspection preparedness
  • Process performance and compliance benchmarking